01 1SM Biomed SDN.BHD.
01 1Hiple Co., Ltd.
01 1Erythromycin
01 1Malaysia
Registrant Name : Hiple Co., Ltd.
Registration Date : 2015-11-17
Registration Number : 20120601-107-F-64-02(1)
Manufacturer Name : SM Biomed SDN.BHD.
Manufacturer Address : Lot 90, Sungai Petani Industrial Estate, 08000 Sungai Petani, Kedah, Malaysia (Erythr...
84
PharmaCompass offers a list of Erythromycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Erythromycin manufacturer or Erythromycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Erythromycin manufacturer or Erythromycin supplier.
A Eritrocina manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eritrocina, including repackagers and relabelers. The FDA regulates Eritrocina manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eritrocina API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eritrocina manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Eritrocina supplier is an individual or a company that provides Eritrocina active pharmaceutical ingredient (API) or Eritrocina finished formulations upon request. The Eritrocina suppliers may include Eritrocina API manufacturers, exporters, distributors and traders.
click here to find a list of Eritrocina suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Eritrocina Drug Master File in Korea (Eritrocina KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Eritrocina. The MFDS reviews the Eritrocina KDMF as part of the drug registration process and uses the information provided in the Eritrocina KDMF to evaluate the safety and efficacy of the drug.
After submitting a Eritrocina KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Eritrocina API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Eritrocina suppliers with KDMF on PharmaCompass.
